Intrauterine Human Chorionic Gonadotrophins (hCG) and Endometrial Treg Cells
- Registration Number
- NCT01064219
- Lead Sponsor
- The Egyptian IVF-ET Center
- Brief Summary
- Intrauterine injection of hCG around the time of implantation may increase endometrial Treg cells and improve implantation. It has been demonstrated that regulatory T cells expand during pregnancy. hCG was found to be secreted by the embryo immediately after fertilization and has chemoattractant properties to Treg cells. 
- Detailed Description
- Aim of the work: 
 To study the effect of intrauterine injection of human chorionic gonadotrophin on the endometrial T regulatory cells (Treg cells)and the electromicroscopic endometrial characteristics.
 Background:
 It has been demonstrated that regulatory T cells expand during pregnancy and are present at the feto-maternal interface at very early stages in pregnancy.
 Rational:
 Intrauterine injection of hCG around the time of implantation may increase endometrial Treg cells and improve implantation.
 Methods:
 Intrauterine injection of 100 IU hCG will be done followed by endometrial biopsy to check for Treg cells and pinopodes.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 20
- Male factor infertility
- Ovulatory factor infertility
- Unexplained infertility
- Female age less than 39
- Azoospermia
- Tubal factor infertility
- Pelvic endometriosis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
- Group - Intervention - Description - intrauterine hCG - human chorionic gonadotrophin - intrauterine injection of 100 hCG followed by endometrial biopsy 
- Primary Outcome Measures
- Name - Time - Method - the presence of Treg cells and pinopodes in the endometrium - 4 weeks 
- Secondary Outcome Measures
- Name - Time - Method - pregnancy rate - 4 weeks 
Trial Locations
- Locations (1)
- Cairo University 🇪🇬- Cairo, Egypt Cairo University🇪🇬Cairo, Egypt
